arrow
S

Stefano Finazzi

department of medical epidemiology
H指数:25
被引数:1,882

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and validation of an UHPLC-MS/MS method for simultaneous quantification of Tazobactam, Meropenem, Vancomycin, Linezolid and Piperacillin in human plasma: application in critically ill patients.

超高效液相色谱-串联质谱法同时定量测定人血浆中他唑巴坦、美罗培南、万古霉素、利奈唑胺和哌拉西林:在危重患者中的应用开发与验证

2026-04-120
PRE
Epidemiology, resistance patterns, and outcomes of candidemia acquired in Italian intensive care units: insights from the GIVITI network (2020–2024)

流行病学、耐药模式及在意大利重症监护病房获得性念珠菌血症的结局:来自GIVITI网络(2020—2024)的见解

2026-04-080
OA
Hospital Acquired Infections Among Solid Organ Transplant Recipients Hospitalized in Intensive Care Unit (2018–2024): A Study of the GiViTI Group

重症监护病房住院的实体器官移植受者中获得的感染(2018–2024):GiViTI小组的一项研究

2025-10-230
OAAI
Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project

通气相关性肺炎的发生率、微生物学及死亡率:一项来自PROSAFE项目的意大利大型危重患者队列研究

2025-05-270
OAAI
Development and external validation of a machine learning model for the prediction of persistent acute kidney injury stage 3 in multi-centric, multi-national intensive care cohorts

在多中心,多国重症监护队列中预测持续性急性肾损伤3期的机器学习模型的开发和外部验证

2024-06-041
OAAI
National ICU Registries as Enablers of Clinical Research and Quality Improvement
2023-09-129
PRE